| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/19/2001 | CA2396368A1 Use of a composition comprising two quaternary ammonium compounds and an organometallic compound for treating viral and fungal infections and diseases |
| 07/19/2001 | CA2396237A1 Selective activation of a th1 or th2 lymphocyte regulated immune response |
| 07/19/2001 | CA2396235A1 Anti-angiogenic proteins and fragments and methods of use thereof |
| 07/19/2001 | CA2394831A1 Monocyte-derived dendritic cell subsets |
| 07/18/2001 | EP1115878A1 Recombinant celo virus and celo virus dna |
| 07/18/2001 | EP1115875A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| 07/18/2001 | EP1115867A1 Human interleukin-b50. therapeutic uses |
| 07/18/2001 | EP1115855A1 RESPONSE REGULATOR CaSSK1 |
| 07/18/2001 | EP1115746A2 Antibodies to mammalian langerhans cell antigen and their uses |
| 07/18/2001 | EP1115743A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115427A1 Time-staggered utilization of tumor cells in combination with intact antibodies for immunization |
| 07/18/2001 | EP1115426A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 07/18/2001 | EP1115425A1 Autoantibody inhibitors |
| 07/18/2001 | EP1115423A1 Methods of downmodulating the immune response to therapeutic proteins |
| 07/18/2001 | EP1115418A2 Aglyco products and methods of use |
| 07/18/2001 | EP1115405A1 Use of certain drugs for treating nerve root injury |
| 07/18/2001 | EP1115382A2 Immunogenic liposome compositions |
| 07/18/2001 | EP1115286A1 Methods for treating or preventing viral infections and associated diseases |
| 07/18/2001 | EP0742830B1 Fusion proteins that include antibody and nonantibody portions |
| 07/18/2001 | EP0667787B1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304452A Attenuated pestiviruses |
| 07/18/2001 | CN1304451A Fusion proteins of i(mycobacterium tuberuculosis) antigens and their uses |
| 07/18/2001 | CN1304442A Delivery of proteins into eukaryotic cells with recombinant Yersinia |
| 07/18/2001 | CN1304317A Nucleic acid encoding hyaluronan synthase and method of use |
| 07/18/2001 | CN1303931A Novel polypeptide-XRN-100 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303869A Egg yellow antiinterleukin -8 antibody, preparation method and its application |
| 07/18/2001 | CN1303862A Novel polypeptide-human shearing and polyadenylation specific factor subunit 66 and polynucleotide for coding said polypeptide |
| 07/17/2001 | US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |
| 07/17/2001 | US6262245 Compounds for immunotherapy of prostate cancer and methods for their use |
| 07/17/2001 | US6262244 Genes coding for the extracellular part of four specific nkg2 (natural killer) transmembrane proteins; useful in treating infectious diseases and cancer |
| 07/17/2001 | US6262238 Via transformation with expression vector containing recombinant gene that codes for immunoglobulin derivative, where a modified gene that codes for a more frequent amino acid is used to produce antibodies free of disulfide bridges |
| 07/17/2001 | US6262235 Leptospiral outer membranes protein, LipL46 |
| 07/17/2001 | US6262026 Chimeric proteins for use in transport of a selected substance into cells |
| 07/17/2001 | US6262025 Their encoded protein products, as well as derivatives and analogs thereof. |
| 07/17/2001 | US6262024 Neuron regulatory factor for promoting neuron survival |
| 07/17/2001 | US6262016 Transferrin receptor genes |
| 07/17/2001 | US6261836 Telomerase |
| 07/17/2001 | US6261823 Subjecting adenovirus preparation to anion-exchange chromatography, eluting virus, then to size exclusion chromatography, and eluting virus |
| 07/17/2001 | US6261820 Fibronolytically active polypeptide |
| 07/17/2001 | US6261818 Nucleotide sequence of cardiac-related ankyrin-repeat protein kinase; antisense agents; probes; primers; vectors; host cells; antibodies; diagnosis and treatment of cardiovascular disorders |
| 07/17/2001 | US6261817 Guaa |
| 07/17/2001 | US6261806 Molecular sequence of swine retrovirus and methods of use |
| 07/17/2001 | US6261802 Ups (ugc) |
| 07/17/2001 | US6261801 Nucleic acids encoding tumor necrosis factor receptor 5 |
| 07/17/2001 | US6261762 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and the use of these DNA clones polypeptides in diagnostic kits |
| 07/17/2001 | US6261573 Mixture of antigen, water soluble polymer and amphiphilic compounds |
| 07/17/2001 | US6261572 In situ administering |
| 07/17/2001 | US6261571 Immunogenic compositions comprising dimeric forms of the human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV) envelope glycoproteins |
| 07/17/2001 | US6261570 Live attenuated virus vaccines for western equine encephalitis virus, eastern equine encephalitis virus, and venezuelan equine encephalitis virus IE and IIIA variants |
| 07/17/2001 | US6261569 Antigens; mixed with carriers; genetic engineering |
| 07/17/2001 | US6261567 Neutralizing antibodies |
| 07/17/2001 | US6261564 Medical diagnosis |
| 07/17/2001 | US6261563 Pseudorabies virus protein |
| 07/17/2001 | US6261562 Compounds for immunotherapy of prostate cancer and methods for their use |
| 07/17/2001 | US6261561 Administering intimin or fusion protein |
| 07/17/2001 | US6261559 Inhalation device |
| 07/17/2001 | US6261558 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 07/17/2001 | US6261556 Binding to matrices; separation |
| 07/17/2001 | US6261281 Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
| 07/17/2001 | CA2151141C Mammalian receptors for interleukin-10 (il-10) |
| 07/17/2001 | CA2110519C Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits detection of bovine herpesvirus type 1 |
| 07/17/2001 | CA2104225C Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases |
| 07/17/2001 | CA2074502C Vaccines |
| 07/17/2001 | CA2055615C Monoclonal antibodies for inducing tolerance |
| 07/17/2001 | CA2034197C Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/12/2001 | WO2001050133A1 Gene expression in corneal diseases |
| 07/12/2001 | WO2001049866A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 07/12/2001 | WO2001049828A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/12/2001 | WO2001049825A1 Methods for protein transfer |
| 07/12/2001 | WO2001049775A2 Antisense antibacterial cell division composition and method |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049729A2 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
| 07/12/2001 | WO2001049722A2 New actinobacillus pleuropneumoniae outer membrane protein and its uses |
| 07/12/2001 | WO2001049720A2 Chemically modified hiv envelope glycoprotein |
| 07/12/2001 | WO2001049716A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 07/12/2001 | WO2001049715A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2001 | WO2001049713A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | WO2001049712A2 Vaccine against isav (infectious salmon anaemia virus) |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049705A2 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 07/12/2001 | WO2001049324A2 Novel colloid synthetic vectors for gene therapy |
| 07/12/2001 | WO2001049321A1 Tnf inhibitors for the treatment of neurological, retinal and muscular disorders |
| 07/12/2001 | WO2001049320A2 Use of hemicellulose microparticles as vaccine adjuvant |
| 07/12/2001 | WO2001049319A1 Composition containing bacterial antigens, used for the prophylaxis and the treatment of allergic diseases |
| 07/12/2001 | WO2001049318A1 Novel chimeric proteins and methods for using the same |
| 07/12/2001 | WO2001049317A2 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| 07/12/2001 | WO2001049310A1 C-ski oncogene-derived peptides for prevention, treatment, and diagnosis of cancer |
| 07/12/2001 | WO2001049243A2 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 07/12/2001 | WO2001049163A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | WO2001004281A3 Dna coding for beta-tubulin and use thereof |
| 07/12/2001 | WO2001004151A3 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 07/12/2001 | WO2000074722A3 Modification of biological elements |
| 07/12/2001 | WO2000068259A3 Vaccine |
| 07/12/2001 | WO2000056144A9 Human sperm surface antigen |
| 07/12/2001 | WO2000041726A9 Noninvasive vascular therapy |
| 07/12/2001 | WO2000034447A8 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 07/12/2001 | WO2000032205A9 Immunomodulatory methods using carbohydrate antigens |
| 07/12/2001 | WO2000004041A3 Methods and molecules relating to cd39-like polypeptides |